ScholarIQanswers from OpenAlex
Aflibercept for neovascular age-related macular degeneration
PaperCitations, authors & open-access status
Aflibercept for neovascular age-related macular degeneration is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Aflibercept for neovascular age-related macular degeneration have?
ScholarIQcitation count
Aflibercept for neovascular age-related macular degeneration has 143 citations in the OpenAlex counts ScholarIQ stores.
When was Aflibercept for neovascular age-related macular degeneration published?
ScholarIQyear
Aflibercept for neovascular age-related macular degeneration has 2016 year in the ScholarIQ index.
What is the open-access status of Aflibercept for neovascular age-related macular degeneration?
ScholarIQoa status
Aflibercept for neovascular age-related macular degeneration has green oa status in the ScholarIQ index.
What is the DOI of Aflibercept for neovascular age-related macular degeneration?
ScholarIQdoi
The DOI for Aflibercept for neovascular age-related macular degeneration is on the source record.
What is the PMID of Aflibercept for neovascular age-related macular degeneration?
ScholarIQpmid
The PMID for Aflibercept for neovascular age-related macular degeneration is on the source record.
What is the OpenAlex record for Aflibercept for neovascular age-related macular degeneration?
ScholarIQopenalex
The OpenAlex for Aflibercept for neovascular age-related macular degeneration is on the source record.